According to Ultragenyx's latest financial reports and stock price the company's current number of shares outstanding is 71,664,493. At the end of 2023 the company had 71,664,493 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 71.66 M | 2.16% |
2022 | 70.15 M | 2.31% |
2021 | 68.57 M | 6.04% |
2020 | 64.66 M | 11.86% |
2019 | 57.8 M | 14.03% |
2018 | 50.69 M | 17.52% |
2017 | 43.13 M | 5.77% |
2016 | 40.78 M | 6.57% |
2015 | 38.26 M | 19.98% |
2014 | 31.89 M | 38.31% |
2013 | 23.06 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Lexicon Pharmaceuticals
LXRX | 244,925,000 | 241.77% | ๐บ๐ธ USA |
Esperion Therapeutics ESPR | 111,869,478 | 56.10% | ๐บ๐ธ USA |
Amicus Therapeutics
FOLD | 295,759,435 | 312.70% | ๐บ๐ธ USA |
BioMarin Pharmaceutical BMRN | 188,219,000 | 162.64% | ๐บ๐ธ USA |